In their recent paper, Stanzani et al sought to ascertain whether the relationship between donor CD4 CD25 regulatory T cells (Tregs) and graft-versus-host disease (GVHD) severity, found in murine transplantation, would hold up in humans. With this aim, they measured CD4 and CD8 T cells coexpressing CD25 within 60 donor grafts infused into matched siblings, reaching the unexpected conclusion that higher numbers of donor CD4 CD25 (as well as CD8 CD25 ) T cells correlated with an increased risk for GVHD. A similar association was stated for the CD4 CD25high subset, but data were not shown. Thus, it was clear that authors referred to Tregs
Acute graft-versus-host disease (aGvHD) is a major cause of morbidity and mortality after allogeneic...
AbstractNaturally arising CD4+CD25+ regulatory T cells (Tregs) have the potential to suppress aberra...
This project received funding from: Fundacão para a Ciência e Tecnologia, Portugal under the Harvard...
Background and Objectives. Graft-versus-host disease (GvHD) remains a major complication of allogene...
Regulatory T cells (Tregs) maintain transplantation tolerance and suppress graft-versus-host disease...
CD4CD25 regulatory T (Treg) cells are potent modulators of alloimmune re-sponses. In murine models ...
Regulatory T cells (Tregs) that constitu-tively express FOXP3 are instrumental to the maintenance of...
Background. The therapeutic efficacy of allogeneic hemopoietic stem cell transplantation (HSCT) larg...
Allogeneic haematopoietic stem cell transplantation (alloHSCT) is an established therapy for many ha...
The subpopulation of regulatory T cells (Treg) was shown to play a key role in alloreactive response...
CD4(+)CD25(+) regulatory T cells (Tregs) are well known to suppress immunopathology induced in lymph...
International audienceAcute graft-versus-host disease (aGVHD), mediated by CD4(+) and CD8(+) effecto...
AbstractIn animal models, CD4+/CD25+T-regulatory cells (Tregs) have been reported to prevent/delay t...
Donor lymphocyte infusion (DLI) can (re-)induce durable remission in relapsing patients after alloge...
Acute graft-versus-host disease (aGvHD) is a frequent complication after allogeneic bone marrow/stem...
Acute graft-versus-host disease (aGvHD) is a major cause of morbidity and mortality after allogeneic...
AbstractNaturally arising CD4+CD25+ regulatory T cells (Tregs) have the potential to suppress aberra...
This project received funding from: Fundacão para a Ciência e Tecnologia, Portugal under the Harvard...
Background and Objectives. Graft-versus-host disease (GvHD) remains a major complication of allogene...
Regulatory T cells (Tregs) maintain transplantation tolerance and suppress graft-versus-host disease...
CD4CD25 regulatory T (Treg) cells are potent modulators of alloimmune re-sponses. In murine models ...
Regulatory T cells (Tregs) that constitu-tively express FOXP3 are instrumental to the maintenance of...
Background. The therapeutic efficacy of allogeneic hemopoietic stem cell transplantation (HSCT) larg...
Allogeneic haematopoietic stem cell transplantation (alloHSCT) is an established therapy for many ha...
The subpopulation of regulatory T cells (Treg) was shown to play a key role in alloreactive response...
CD4(+)CD25(+) regulatory T cells (Tregs) are well known to suppress immunopathology induced in lymph...
International audienceAcute graft-versus-host disease (aGVHD), mediated by CD4(+) and CD8(+) effecto...
AbstractIn animal models, CD4+/CD25+T-regulatory cells (Tregs) have been reported to prevent/delay t...
Donor lymphocyte infusion (DLI) can (re-)induce durable remission in relapsing patients after alloge...
Acute graft-versus-host disease (aGvHD) is a frequent complication after allogeneic bone marrow/stem...
Acute graft-versus-host disease (aGvHD) is a major cause of morbidity and mortality after allogeneic...
AbstractNaturally arising CD4+CD25+ regulatory T cells (Tregs) have the potential to suppress aberra...
This project received funding from: Fundacão para a Ciência e Tecnologia, Portugal under the Harvard...